Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
Longitudinal interferon-β effects in multiple sclerosis: Differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
High risk of cardiovascular diseases after diagnosis of multiple sclerosis.
Mystery Case: Balo concentric sclerosis.
Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
MS risk genes are transcriptionally regulated in CSF leukocytes at relapse.
Assay selection affects John Cunningham virus serostatus classification in multiple sclerosis.
Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders.
Reducing falls and improving mobility in multiple sclerosis.
Dynamic change in magnetic resonance imaging of patients with neuromyelitis optica.
Outer retinal changes following acute optic neuritis.
Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis.
Neuromyelitis Optica Spectrum Disorder Associated with Cervical Spondylosis.
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling.
Which immune cells matter? The immunopathogenesis of multiple sclerosis.
Clostridia as agents of zoonotic disease.
Foot placement patterns of female rollator users with multiple sclerosis in the community.
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.
Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy.
Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
Transvascular autonomic modulation: a modified balloon angioplasty technique for the treatment of autonomic dysfunction in multiple sclerosis patients.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Pages
« first
‹ previous
…
246
247
248
249
250
251
252
253
254
…
next ›
last »